L&G Pharma Breakthrough UCITS ETF | BIOT

Register to Unlock Ratings
Performance History30/09/2021
Growth of 1,000 (GBP) Advanced Graph
L&G Pharma Breakthrough UCITS ETF
          | 
          BIOT
Fund--8.323.2-0.7
+/-Cat---11.9-2.8-0.3
+/-B’mrk---12.00.7-9.6
 
Key Stats
Closing Price
22/10/2021
 USD 12.97
Day Change 0.33%
Morningstar Category™ Sector Equity Biotechnology
Volume 0
Exchange LONDON STOCK EXCHANGE, THE
ISIN IE00BF0H7608
Fund Size (Mil)
22/10/2021
 USD 35.04
Share Class Size (Mil)
22/10/2021
 USD 35.04
Ongoing Charge
17/02/2021
  0.49%
Investment Objective: L&G Pharma Breakthrough UCITS ETF | BIOT
The objective of the fund is to provide exposure to a basket of stocks of companies that are actively engaged in the research, development and/or manufacturing of orphan drugs. The Index selects stocks that meet certain size and liquidity requirements using a two-fold approach that is primarily based on the trend in the valuation of a company’s orphan drug portfolio and its overall revenue forecasts.
Returns
Trailing Returns (GBP)22/10/2021
YTD-1.67
3 Years Annualised7.20
5 Years Annualised-
10 Years Annualised-
12 Month Yield 0.00
Management
Manager Name
Start Date
-
-
Inception Date
18/01/2018
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
Solactive Pharma Breakthrough V NR USDNASDAQ Biotechnology TR USD
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNo
GrowthYes
IncomeNo
HedgingNot Specific
OtherYes
Portfolio Profile for  L&G Pharma Breakthrough UCITS ETF | BIOT21/10/2021
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stock99.920.0099.92
Bond0.000.000.00
Property0.000.000.00
Cash0.080.000.08
Other0.000.000.00
Top 5 Regions%
United States58.81
Europe - ex Euro13.40
Japan9.10
Eurozone6.66
Australasia5.47
Top 5 Sectors%
Healthcare100.00
Top 5 HoldingsSector%
Endo International PLCHealthcareHealthcare7.43
Supernus Pharmaceuticals IncHealthcareHealthcare3.76
Alnylam Pharmaceuticals IncHealthcareHealthcare3.64
Xencor IncHealthcareHealthcare3.60
Sarepta Therapeutics IncHealthcareHealthcare3.54
L&G Pharma Breakthrough UCITS ETF | BIOT

Related

In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)